Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (2765)	5/14/1999 4:34:00 PM
From: JOEBT1	Read Replies (2) of 10280

Peter--The problem is that this shakes the foundations for revenue/earnings projections for SEPR. If J&J backs out, other major partners might pull out if the ICE versions are not measurably better than the existing drug. The earnings projections were made assuming a high probability of success for ICEs--J&J's action indicates a much higher risk in these projections.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next